Novel video-based platform increased stroke education after 90 days

Key takeaways:

• Patients who received MyStroke were more likely to correctly identify their stroke etiology.
• Those with less formal education expressed greater satisfaction and quality of life with MyStroke at 90 days.

Among a small cohort of adults hospitalized for stroke and their caregivers, use of a novel video-based platform increased education about the condition after 90 days, according to a presentation from the International Stroke Conference.

“Stroke knowledge, risk factor awareness, and medication adherence are critical to post-stroke outcomes,” Christopher G. Favilla, MD, an assistant professor of neurology at the Hospital of the University of Pennsylvania, and colleagues wrote.

Favilla and colleagues sought to quantify the impact of MyStroke, a personalized video-based educational platform in patients and caregivers after discharge from the hospital following stroke incidence, and to test the hypothesis that such a platform improves patient satisfaction and knowledge of the condition.

In a single-center randomized trial, stroke patients (n = 96) and caregivers (n = 24) were randomized 1:1 to receive standard stroke education (n = 59) during hospitalization or access to MyStroke (n = 61), with information regarding risk factors, medications and post-stroke lifestyle. Satisfaction with the platform, improvements to quality of life and stroke knowledge were assessed 90 days after discharge.

According to results, satisfaction with stroke education was higher among those who received MyStroke compared with standard education, and those provided the platform were more likely to correctly identify their stroke etiology; however, no effect was observed regarding risk factor recognition, medication awareness or quality of life.

Data further showed those without a college degree experienced a larger educational benefit and improved quality of life.

“The MyStroke personalized video-based education platform improved stroke knowledge, and then impact was augmented in subjects with less formal education,” Favilla and colleagues wrote. “A multicenter trial is needed to confirm these results, clarify generalizability and target clinically relevant metrics such as stroke recurrence or adherence.”